載入...
Do LORIS trial eligibility criteria identify a ductal carcinoma in situ (DCIS) patient population at low risk of upgrade to invasive carcinoma?
BACKGROUND: The Surgery versus Active Monitoring for Low-Risk DCIS (LORIS) trial is studying the safety of monitoring core-biopsy diagnosed low-risk ductal carcinoma in situ (DCIS) without excision. We sought to determine the incidence and characteristics of synchronous invasive carcinoma found in L...
Na minha lista:
| 發表在: | Ann Surg Oncol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070657/ https://ncbi.nlm.nih.gov/pubmed/27172775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5268-2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|